Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)

Pulmonx (LUNG) has disclosed Income from Continuing Operations for 7 consecutive years, with 13929000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 1.58% to 13929000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 56710000.0, a 0.78% increase, with the full-year FY2024 number at 56394000.0, up 7.31% from a year prior.
  • Income from Continuing Operations was 13929000.0 for Q3 2025 at Pulmonx, up from 15196000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10181000.0 in Q3 2021 to a low of 16155000.0 in Q2 2023.
  • A 5-year average of 14128947.37 and a median of 14172000.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 163.76% in 2021, then grew 13.31% in 2024.
  • Pulmonx's Income from Continuing Operations stood at 13006000.0 in 2021, then dropped by 9.82% to 14283000.0 in 2022, then increased by 2.6% to 13911000.0 in 2023, then grew by 5.56% to 13137000.0 in 2024, then dropped by 6.03% to 13929000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Income from Continuing Operations are 13929000.0 (Q3 2025), 15196000.0 (Q2 2025), and 14448000.0 (Q1 2025).